1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
21.40 -0.46 (-2.10%)
1.2M
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Genmab - ADR - GMAB - stock price prediction, stock price target, analyst ratings from 9 analysts

Genmab - ADR has a share price target of US$ 30, revenue growth forecast of 22.6%, and profit growth estimate of -3.5% for FY25, based on top 9 analyst calls.